Additional comments on the 2022 Joint ESAIC/ESRA guidelines: regional anaesthesia in patients on antithrombotic drugs
- PMID: 36479995
- DOI: 10.1097/EJA.0000000000001732
Additional comments on the 2022 Joint ESAIC/ESRA guidelines: regional anaesthesia in patients on antithrombotic drugs
Comment on
-
Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines.Eur J Anaesthesiol. 2022 Feb 1;39(2):100-132. doi: 10.1097/EJA.0000000000001600. Eur J Anaesthesiol. 2022. PMID: 34980845
References
-
- Mogavero T. Regional anaesthesia in patients receiving antithrombotic therapy: low evidence and conservative views. Eur J Anaesthesiol 2023; 40:67–68.
-
- Kietaibl S, Ferrandis R, Godier A, et al. Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines. Eur J Anaesthesiol 2022; 39:100–132.
-
- Rosencher N, Bonnet MP, Sessler DI. Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies. Anaesthesia 2007; 62:1154–1160.
-
- Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI): how does thrombin regulate fibrinolysis? Ann Med 2006; 38:378–388.
-
- Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002; 359:1721–1726.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources